Patent · US Active

Compounds and methods for kinase modulation, and indications therefor

US10301280B2 · kind B2 · utility

4Cited by
59References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 12, 2017
Grant dateMay 28, 2019
Priority date
Expiry dateJun 12, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/65616
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds active on c-kit protein kinases or mutant c-kit protein kinases having any mutations are described, as well as methods of making and using such compounds to treat diseases and conditions associated with aberrant activity of the c-kit protein kinases and/or mutant c-kit protein kinases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.